发明授权
EP1773796B1 DERIVES D'OXOPIPERIDINE, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE
有权
OXOPIPERIDINDERIVATE,生产和治疗用途
- 专利标题: DERIVES D'OXOPIPERIDINE, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE
- 专利标题(英): Oxopiperidine derivatives, preparation and therapeutic use thereof
- 专利标题(中): OXOPIPERIDINDERIVATE,生产和治疗用途
-
申请号: EP05790990.5申请日: 2005-07-20
-
公开(公告)号: EP1773796B1公开(公告)日: 2010-03-03
- 发明人: BRAUN, Alain , COURTEMANCHE, Gilles , CRESPIN, Olivier , FETT, Eykmar , PASCAL, Cécile
- 申请人: Sanofi-Aventis
- 申请人地址: 174, Avenue de France 75013 Paris FR
- 专利权人: Sanofi-Aventis
- 当前专利权人: Sanofi-Aventis
- 当前专利权人地址: 174, Avenue de France 75013 Paris FR
- 代理机构: Morel-Pécheux, Muriel
- 优先权: FR0408369 20040729
- 国际公布: WO2006021655 20060302
- 主分类号: C07D295/108
- IPC分类号: C07D295/108 ; C07D451/04 ; A61K31/445 ; A61P15/00
摘要:
The invention concerns oxopiperidine derivatives of general formula (I) wherein: n = 1; Ra, Ra′, Rb et Rb′ represent hydrogen atoms or alkyl or cycloalkyl groups, or Rb and Rb′ together form a carbon bridge; R1 represents an alkyl or cycloalkyl group; R2 represents a heteroaryl group; R3 represents 1 to 3 groups selected among halogen atoms and alkyl, cycloalkyl, -OR, -NRR', -CO-NRR', -NR-CO-R', -NR-CO-NRR1, -NR-COOR', -NO2, -CN and COOR groups; R5 represents a hydrogen atom or an alkyl group; R4 is selected among the groups of formulae (a), (b) and (c), wherein p = 0, 1, 2 or 3, m = 0, 1 or 2, and X represents a -C(R6)(R7)- or -N(R10)- member. The invention also concerns a method for preparing said derivatives and their therapeutic use.
公开/授权文献
信息查询